Bile acids and cardiovascular function in cirrhosis
Research output: Contribution to journal › Review › Research › peer-review
Standard
Bile acids and cardiovascular function in cirrhosis. / Voiosu, Andrei; Wiese, Signe; Voiosu, Theodor; Bendtsen, Flemming; Møller, Søren.
In: Liver International, Vol. 37, No. 10, 10.2017, p. 1420-1430.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Bile acids and cardiovascular function in cirrhosis
AU - Voiosu, Andrei
AU - Wiese, Signe
AU - Voiosu, Theodor
AU - Bendtsen, Flemming
AU - Møller, Søren
N1 - © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2017/10
Y1 - 2017/10
N2 - Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly unknown. Experimental models have proven the cardiotoxic effects of bile acids and recent studies of their varied receptor-mediated functions offer new insight into their involvement in cardiovascular dysfunction in cirrhosis. Bile acid receptors such as farnesoid X-activated receptor and TGR5 are currently under investigation as potential therapeutic targets in a variety of pathological conditions. These receptors have also recently been identified in cardiomyocytes, vascular endothelial cells and smooth muscle cells where they seem to play an important role in cellular metabolism. Chronic cholestasis leading to abnormal levels of circulating bile acids alters the normal signalling pathways and contributes to the development of profound cardiovascular disturbances. This review summarizes the evidence regarding the role of bile acids and their receptors in the generation of cardiovascular dysfunction in cirrhosis.
AB - Cirrhotic cardiomyopathy and the hyperdynamic syndrome are clinically important complications of cirrhosis, but their exact pathogenesis is still partly unknown. Experimental models have proven the cardiotoxic effects of bile acids and recent studies of their varied receptor-mediated functions offer new insight into their involvement in cardiovascular dysfunction in cirrhosis. Bile acid receptors such as farnesoid X-activated receptor and TGR5 are currently under investigation as potential therapeutic targets in a variety of pathological conditions. These receptors have also recently been identified in cardiomyocytes, vascular endothelial cells and smooth muscle cells where they seem to play an important role in cellular metabolism. Chronic cholestasis leading to abnormal levels of circulating bile acids alters the normal signalling pathways and contributes to the development of profound cardiovascular disturbances. This review summarizes the evidence regarding the role of bile acids and their receptors in the generation of cardiovascular dysfunction in cirrhosis.
U2 - 10.1111/liv.13394
DO - 10.1111/liv.13394
M3 - Review
C2 - 28222247
VL - 37
SP - 1420
EP - 1430
JO - Liver International
JF - Liver International
SN - 1478-3223
IS - 10
ER -
ID: 195012277